[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Live Attenuated Vaccines Sales Market Report 2021

August 2016 | 105 pages | ID: G72ACFB2229EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Live Attenuated Vaccines

Revenue, means the sales value of Live Attenuated Vaccines

This report studies sales (consumption) of Live Attenuated Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Astellas Pharma Inc
  • CSL Limited
  • Emergent BioSolutions, Inc
  • GlaxoSmithKline
  • Johnson & Johnson
  • MedImmune, LLC
  • Merck & Co
  • Pfizer
  • Sanofi Pasteur
  • Serum Institute
  • India Pvt. Ltd. (India)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Live Attenuated Vaccines in these regions, from 2011 to 2021 (forecast), like
  • North America
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Pneumococcal
  • Influenza
  • HPV
  • Hepatitis
  • Rotavirus
  • DTP
  • Polio
  • MMR
Split by applications, this report focuses on sales, market share and growth rate of Live Attenuated Vaccines in each application, can be divided into
  • Pediatric
  • Adult
  • Application 3
Global Live Attenuated Vaccines Sales Market Report 2021

1 LIVE ATTENUATED VACCINES OVERVIEW

1.1 Product Overview and Scope of Live Attenuated Vaccines
1.2 Classification of Live Attenuated Vaccines
  1.2.1 Pneumococcal
  1.2.2 Influenza
  1.2.3 HPV
  1.2.4 Hepatitis
  1.2.5 Rotavirus
  1.2.6 DTP
  1.2.7 Polio
  1.2.8 MMR
1.3 Applications of Live Attenuated Vaccines
  1.3.1 Pediatric
  1.3.2 Adult
  1.3.3 Application
1.4 Live Attenuated Vaccines Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Live Attenuated Vaccines (2011-2021)
  1.5.1 Global Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
  1.5.2 Global Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
  1.5.3 Global Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)

2 GLOBAL LIVE ATTENUATED VACCINES COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Live Attenuated Vaccines Market Competition by Manufacturers
  2.1.1 Global Live Attenuated Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Live Attenuated Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Live Attenuated Vaccines (Volume and Value) by Type
  2.2.1 Global Live Attenuated Vaccines Sales and Market Share by Type (2011-2021)
  2.2.2 Global Live Attenuated Vaccines Revenue and Market Share by Type (2011-2021)
2.3 Global Live Attenuated Vaccines (Volume and Value) by Regions
  2.3.1 Global Live Attenuated Vaccines Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Live Attenuated Vaccines Revenue and Market Share by Regions (2011-2021)
2.4 Global Live Attenuated Vaccines (Volume) by Application

3 NORTH AMERICA LIVE ATTENUATED VACCINES (VOLUME, VALUE AND SALES PRICE

3.1 North America Live Attenuated Vaccines Sales and Value (2011-2021)
  3.1.1 North America Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
  3.1.2 North America Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
  3.1.3 North America Live Attenuated Vaccines Sales Price Trend (2011-2021)
3.2 North America Live Attenuated Vaccines Sales and Market Share by Manufacturers
3.3 North America Live Attenuated Vaccines Sales and Market Share by Type
3.4 North America Live Attenuated Vaccines Sales and Market Share by Applications

4 CHINA LIVE ATTENUATED VACCINES (VOLUME, VALUE AND SALES PRICE

4.1 China Live Attenuated Vaccines Sales and Value (2011-2021)
  4.1.1 China Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
  4.1.2 China Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
  4.1.3 China Live Attenuated Vaccines Sales Price Trend (2011-2021)
4.2 China Live Attenuated Vaccines Sales and Market Share by Manufacturers
4.3 China Live Attenuated Vaccines Sales and Market Share by Type
4.4 China Live Attenuated Vaccines Sales and Market Share by Applications

5 EUROPE LIVE ATTENUATED VACCINES (VOLUME, VALUE AND SALES PRICE

5.1 Europe Live Attenuated Vaccines Sales and Value (2011-2021)
  5.1.1 Europe Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
  5.1.2 Europe Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Live Attenuated Vaccines Sales Price Trend (2011-2021)
5.2 Europe Live Attenuated Vaccines Sales and Market Share by Manufacturers
5.3 Europe Live Attenuated Vaccines Sales and Market Share by Type
5.4 Europe Live Attenuated Vaccines Sales and Market Share by Applications

6 JAPAN LIVE ATTENUATED VACCINES (VOLUME, VALUE AND SALES PRICE

6.1 Japan Live Attenuated Vaccines Sales and Value (2011-2021)
  6.1.1 Japan Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
  6.1.2 Japan Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Live Attenuated Vaccines Sales Price Trend (2011-2021)
6.2 Japan Live Attenuated Vaccines Sales and Market Share by Manufacturers
6.3 Japan Live Attenuated Vaccines Sales and Market Share by Type
6.4 Japan Live Attenuated Vaccines Sales and Market Share by Applications

7 SOUTHEAST ASIA LIVE ATTENUATED VACCINES (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Live Attenuated Vaccines Sales and Value (2011-2021)
  7.1.1 Southeast Asia Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Live Attenuated Vaccines Sales Price Trend (2011-2021)
7.2 Southeast Asia Live Attenuated Vaccines Sales and Market Share by Manufacturers
7.3 Southeast Asia Live Attenuated Vaccines Sales and Market Share by Type
7.4 Southeast Asia Live Attenuated Vaccines Sales and Market Share by Applications

8 INDIA LIVE ATTENUATED VACCINES (VOLUME, VALUE AND SALES PRICE

8.1 India Live Attenuated Vaccines Sales and Value (2011-2021)
  8.1.1 India Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
  8.1.2 India Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
  8.1.3 India Live Attenuated Vaccines Sales Price Trend (2011-2021)
8.2 India Live Attenuated Vaccines Sales and Market Share by Manufacturers
8.3 India Live Attenuated Vaccines Sales and Market Share by Type
8.4 India Live Attenuated Vaccines Sales and Market Share by Applications

9 GLOBAL LIVE ATTENUATED VACCINES MANUFACTURERS ANALYSIS

9.1 Astellas Pharma Inc
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Live Attenuated Vaccines Product Type and Technology
    9.1.2.1 Pneumococcal
    9.1.2.2 Influenza
  9.1.3 Live Attenuated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.2 CSL Limited
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Live Attenuated Vaccines Product Type and Technology
    9.2.2.1 Pneumococcal
    9.2.2.2 Influenza
  9.2.3 Live Attenuated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.3 Emergent BioSolutions, Inc
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Live Attenuated Vaccines Product Type and Technology
    9.3.2.1 Pneumococcal
    9.3.2.2 Influenza
  9.3.3 Live Attenuated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.4 GlaxoSmithKline
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Live Attenuated Vaccines Product Type and Technology
    9.4.2.1 Pneumococcal
    9.4.2.2 Influenza
  9.4.3 Live Attenuated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Johnson & Johnson
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Live Attenuated Vaccines Product Type and Technology
    9.5.2.1 Pneumococcal
    9.5.2.2 Influenza
  9.5.3 Live Attenuated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.6 MedImmune, LLC
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Live Attenuated Vaccines Product Type and Technology
    9.6.2.1 Pneumococcal
    9.6.2.2 Influenza
  9.6.3 Live Attenuated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.7 Merck & Co
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Live Attenuated Vaccines Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Live Attenuated Vaccines Sales, Revenue, Price of Company One (2015 and 2017)
9.8 Pfizer
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Live Attenuated Vaccines Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Live Attenuated Vaccines Sales, Revenue, Price of Company One (2015 and 2018)
9.9 Sanofi Pasteur
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Live Attenuated Vaccines Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Live Attenuated Vaccines Sales, Revenue, Price of Company One (2015 and 2019)
9.10 Serum Institute
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Live Attenuated Vaccines Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Live Attenuated Vaccines Sales, Revenue, Price of Company One (2015 and 2021)
9.11 India Pvt. Ltd. (India)

10 LIVE ATTENUATED VACCINES TECHNOLOGY AND DEVELOPMENT TREND

10.1 Live Attenuated Vaccines Technology Analysis
10.2 Live Attenuated Vaccines Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Live Attenuated Vaccines
Table Classification of Live Attenuated Vaccines
Figure Global Sales Market Share of Live Attenuated Vaccines by Type in 2015
Figure Pneumococcal Picture
Figure Influenza Picture
Figure HPV Picture
Figure Hepatitis Picture
Figure Rotavirus Picture
Figure DTP Picture
Figure Polio Picture
Figure MMR Picture
Table Applications of Live Attenuated Vaccines
Figure Global Sales Market Share of Live Attenuated Vaccines by Applications in 2015
Figure Pediatric Examples
Figure Adult Examples
Figure North America Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure China Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure India Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Table Global Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure Global Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
Figure Global Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Table Global Live Attenuated Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Global Live Attenuated Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Live Attenuated Vaccines Sales Share by Manufacturers
Figure 2016 Live Attenuated Vaccines Sales Share by Manufacturers
Table Global Live Attenuated Vaccines Revenue by Manufacturers (2015 and 2016)
Table Global Live Attenuated Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Live Attenuated Vaccines Revenue Share by Manufacturers
Table 2016 Global Live Attenuated Vaccines Revenue Share by Manufacturers
Table Global Live Attenuated Vaccines Sales and Market Share by Type (2011-2021)
Table Global Live Attenuated Vaccines Sales Share by Type (2011-2021)
Figure Sales Market Share of Live Attenuated Vaccines by Type (2011-2021)
Figure Global Live Attenuated Vaccines Sales Growth Rate by Type (2011-2021)
Table Global Live Attenuated Vaccines Revenue and Market Share by Type (2011-2021)
Table Global Live Attenuated Vaccines Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Live Attenuated Vaccines by Type (2011-2021)
Figure Global Live Attenuated Vaccines Revenue Growth Rate by Type (2011-2021)
Table Global Live Attenuated Vaccines Sales and Market Share by Regions (2011-2021)
Table Global Live Attenuated Vaccines Sales Share by Regions (2011-2021)
Figure Sales Market Share of Live Attenuated Vaccines by Regions (2011-2021)
Figure Global Live Attenuated Vaccines Sales Growth Rate by Regions (2011-2021)
Table Global Live Attenuated Vaccines Revenue and Market Share by Regions (2011-2021)
Table Global Live Attenuated Vaccines Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Live Attenuated Vaccines by Regions (2011-2021)
Figure Global Live Attenuated Vaccines Revenue Growth Rate by Regions (2011-2021)
Table Global Live Attenuated Vaccines Sales and Market Share by Application (2011-2021)
Table Global Live Attenuated Vaccines Sales Share by Application (2011-2021)
Figure Sales Market Share of Live Attenuated Vaccines by Application (2011-2021)
Figure Global Live Attenuated Vaccines Sales Growth Rate by Application (2011-2021)
Figure North America Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
Figure North America Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure North America Live Attenuated Vaccines Sales Price Trend (2011-2021)
Table North America Live Attenuated Vaccines Sales by Manufacturers (2015 and 2016)
Table North America Live Attenuated Vaccines Market Share by Manufacturers (2015 and 2016)
Table North America Live Attenuated Vaccines Sales by Type (2015 and 2016)
Table North America Live Attenuated Vaccines Market Share by Type (2015 and 2016)
Table North America Live Attenuated Vaccines Sales by Applications (2015 and 2016)
Table North America Live Attenuated Vaccines Market Share by Applications (2015 and 2016)
Figure Europe Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
Figure Europe Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Live Attenuated Vaccines Sales Price Trend (2011-2021)
Table Europe Live Attenuated Vaccines Sales by Manufacturers (2015 and 2016)
Table Europe Live Attenuated Vaccines Market Share by Manufacturers (2015 and 2016)
Table Europe Live Attenuated Vaccines Sales by Type (2015 and 2016)
Table Europe Live Attenuated Vaccines Market Share by Type (2015 and 2016)
Table Europe Live Attenuated Vaccines Sales by Applications (2015 and 2016)
Table Europe Live Attenuated Vaccines Market Share by Applications (2015 and 2016)
Figure China Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
Figure China Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure China Live Attenuated Vaccines Sales Price Trend (2011-2021)
Table China Live Attenuated Vaccines Sales by Manufacturers (2015 and 2016)
Table China Live Attenuated Vaccines Market Share by Manufacturers (2015 and 2016)
Table China Live Attenuated Vaccines Sales by Type (2015 and 2016)
Table China Live Attenuated Vaccines Market Share by Type (2015 and 2016)
Table China Live Attenuated Vaccines Sales by Applications (2015 and 2016)
Table China Live Attenuated Vaccines Market Share by Applications (2015 and 2016)
Figure Japan Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
Figure Japan Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Live Attenuated Vaccines Sales Price Trend (2011-2021)
Table Japan Live Attenuated Vaccines Sales by Manufacturers (2015 and 2016)
Table Japan Live Attenuated Vaccines Market Share by Manufacturers (2015 and 2016)
Table Japan Live Attenuated Vaccines Sales by Type (2015 and 2016)
Table Japan Live Attenuated Vaccines Market Share by Type (2015 and 2016)
Table Japan Live Attenuated Vaccines Sales by Applications (2015 and 2016)
Table Japan Live Attenuated Vaccines Market Share by Applications (2015 and 2016)
Figure India Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
Figure India Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure India Live Attenuated Vaccines Sales Price Trend (2011-2021)
Table India Live Attenuated Vaccines Sales by Manufacturers (2015 and 2016)
Table India Live Attenuated Vaccines Market Share by Manufacturers (2015 and 2016)
Table India Live Attenuated Vaccines Sales by Type (2015 and 2016)
Table India Live Attenuated Vaccines Market Share by Type (2015 and 2016)
Table India Live Attenuated Vaccines Sales by Applications (2015 and 2016)
Table India Live Attenuated Vaccines Market Share by Applications (2015 and 2016)
Figure Southeast Asia Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
Figure Southeast Asia Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Live Attenuated Vaccines Sales Price Trend (2011-2021)
Table Southeast Asia Live Attenuated Vaccines Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Live Attenuated Vaccines Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Live Attenuated Vaccines Sales by Type (2015 and 2016)
Table Southeast Asia Live Attenuated Vaccines Market Share by Type (2015 and 2016)
Table Southeast Asia Live Attenuated Vaccines Sales by Applications (2015 and 2016)
Table Southeast Asia Live Attenuated Vaccines Market Share by Applications (2015 and 2016)
Table Astellas Pharma Inc Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
Table CSL Limited Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
Table Emergent BioSolutions, Inc Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table MedImmune, LLC Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
Table Merck & Co Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Sanofi Pasteur Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
Table Serum Institute Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
Table India Pvt. Ltd. (India) Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)


More Publications